Prevalence of prothrombotic polymorphisms in a selected cohort of cryptogenic and noncryptogenic ischemic stroke patients

Rocco Salvatore Calabrò, Paolino La Spina, Salvatore Serra, Angelina Laganà, Paolo Postorino, Rodolfo Savica, Corrado Mammì, Carmelo Laganà, Rosa Musolino

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Ischemic stroke is a complex multifactorial disease and approximately 30%, especially in the young, are cryptogenic. In some of the patients with cryptogenic ischemic stroke the underlying risk factor may be a prothrombotic state. We studied 101 patients with ischemic stroke under 55 years of age. All the patients underwent an extensive diagnostic evaluation to determine the cause of stroke. Common variations in the genes encoding factor V, prothrombin, 5,10-methylenetetrahydrofolate reductase, plasminogen activator inhibitor-1, and human platelet alloantigens-1 were evaluated. Of the 101 patients with ischemic stroke, 28 patients had cryptogenic ischemic stroke. At least one of the different genetic polymorphisms investigated was present in 44% patients in the total group and in 48% of patients with cryptogenic ischemic stroke. In this study population under 55 years of age there was no significant difference in the prevalence of various genetic polymorphisms, factor V, prothrombin, 5,10-methylenetetrahydrofolate reductase, plasminogen activator inhibitor-1, and human platelet alloantigens) in patients with cryptogenic ischemic stroke and in patients with ischemic stroke of determined cause.

Original languageEnglish (US)
Pages (from-to)636-637
Number of pages2
JournalNeurology India
Volume57
Issue number5
DOIs
StatePublished - Dec 1 2009
Externally publishedYes

Fingerprint

Stroke
Human Platelet Antigens
Methylenetetrahydrofolate Reductase (NADPH2)
Factor V
Plasminogen Activator Inhibitor 1
Prothrombin
Genetic Polymorphisms
Population
Genes

Keywords

  • Cryptogenic stroke
  • Juvenile ischemic stroke
  • Prothrombotic genetic polymorphisms

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Prevalence of prothrombotic polymorphisms in a selected cohort of cryptogenic and noncryptogenic ischemic stroke patients. / Calabrò, Rocco Salvatore; La Spina, Paolino; Serra, Salvatore; Laganà, Angelina; Postorino, Paolo; Savica, Rodolfo; Mammì, Corrado; Laganà, Carmelo; Musolino, Rosa.

In: Neurology India, Vol. 57, No. 5, 01.12.2009, p. 636-637.

Research output: Contribution to journalArticle

Calabrò, RS, La Spina, P, Serra, S, Laganà, A, Postorino, P, Savica, R, Mammì, C, Laganà, C & Musolino, R 2009, 'Prevalence of prothrombotic polymorphisms in a selected cohort of cryptogenic and noncryptogenic ischemic stroke patients', Neurology India, vol. 57, no. 5, pp. 636-637. https://doi.org/10.4103/0028-3886.57819
Calabrò, Rocco Salvatore ; La Spina, Paolino ; Serra, Salvatore ; Laganà, Angelina ; Postorino, Paolo ; Savica, Rodolfo ; Mammì, Corrado ; Laganà, Carmelo ; Musolino, Rosa. / Prevalence of prothrombotic polymorphisms in a selected cohort of cryptogenic and noncryptogenic ischemic stroke patients. In: Neurology India. 2009 ; Vol. 57, No. 5. pp. 636-637.
@article{88af68b5e2fe4d99b85fb8562b51fa1a,
title = "Prevalence of prothrombotic polymorphisms in a selected cohort of cryptogenic and noncryptogenic ischemic stroke patients",
abstract = "Ischemic stroke is a complex multifactorial disease and approximately 30{\%}, especially in the young, are cryptogenic. In some of the patients with cryptogenic ischemic stroke the underlying risk factor may be a prothrombotic state. We studied 101 patients with ischemic stroke under 55 years of age. All the patients underwent an extensive diagnostic evaluation to determine the cause of stroke. Common variations in the genes encoding factor V, prothrombin, 5,10-methylenetetrahydrofolate reductase, plasminogen activator inhibitor-1, and human platelet alloantigens-1 were evaluated. Of the 101 patients with ischemic stroke, 28 patients had cryptogenic ischemic stroke. At least one of the different genetic polymorphisms investigated was present in 44{\%} patients in the total group and in 48{\%} of patients with cryptogenic ischemic stroke. In this study population under 55 years of age there was no significant difference in the prevalence of various genetic polymorphisms, factor V, prothrombin, 5,10-methylenetetrahydrofolate reductase, plasminogen activator inhibitor-1, and human platelet alloantigens) in patients with cryptogenic ischemic stroke and in patients with ischemic stroke of determined cause.",
keywords = "Cryptogenic stroke, Juvenile ischemic stroke, Prothrombotic genetic polymorphisms",
author = "Calabr{\`o}, {Rocco Salvatore} and {La Spina}, Paolino and Salvatore Serra and Angelina Lagan{\`a} and Paolo Postorino and Rodolfo Savica and Corrado Mamm{\`i} and Carmelo Lagan{\`a} and Rosa Musolino",
year = "2009",
month = "12",
day = "1",
doi = "10.4103/0028-3886.57819",
language = "English (US)",
volume = "57",
pages = "636--637",
journal = "Neurology India",
issn = "0028-3886",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "5",

}

TY - JOUR

T1 - Prevalence of prothrombotic polymorphisms in a selected cohort of cryptogenic and noncryptogenic ischemic stroke patients

AU - Calabrò, Rocco Salvatore

AU - La Spina, Paolino

AU - Serra, Salvatore

AU - Laganà, Angelina

AU - Postorino, Paolo

AU - Savica, Rodolfo

AU - Mammì, Corrado

AU - Laganà, Carmelo

AU - Musolino, Rosa

PY - 2009/12/1

Y1 - 2009/12/1

N2 - Ischemic stroke is a complex multifactorial disease and approximately 30%, especially in the young, are cryptogenic. In some of the patients with cryptogenic ischemic stroke the underlying risk factor may be a prothrombotic state. We studied 101 patients with ischemic stroke under 55 years of age. All the patients underwent an extensive diagnostic evaluation to determine the cause of stroke. Common variations in the genes encoding factor V, prothrombin, 5,10-methylenetetrahydrofolate reductase, plasminogen activator inhibitor-1, and human platelet alloantigens-1 were evaluated. Of the 101 patients with ischemic stroke, 28 patients had cryptogenic ischemic stroke. At least one of the different genetic polymorphisms investigated was present in 44% patients in the total group and in 48% of patients with cryptogenic ischemic stroke. In this study population under 55 years of age there was no significant difference in the prevalence of various genetic polymorphisms, factor V, prothrombin, 5,10-methylenetetrahydrofolate reductase, plasminogen activator inhibitor-1, and human platelet alloantigens) in patients with cryptogenic ischemic stroke and in patients with ischemic stroke of determined cause.

AB - Ischemic stroke is a complex multifactorial disease and approximately 30%, especially in the young, are cryptogenic. In some of the patients with cryptogenic ischemic stroke the underlying risk factor may be a prothrombotic state. We studied 101 patients with ischemic stroke under 55 years of age. All the patients underwent an extensive diagnostic evaluation to determine the cause of stroke. Common variations in the genes encoding factor V, prothrombin, 5,10-methylenetetrahydrofolate reductase, plasminogen activator inhibitor-1, and human platelet alloantigens-1 were evaluated. Of the 101 patients with ischemic stroke, 28 patients had cryptogenic ischemic stroke. At least one of the different genetic polymorphisms investigated was present in 44% patients in the total group and in 48% of patients with cryptogenic ischemic stroke. In this study population under 55 years of age there was no significant difference in the prevalence of various genetic polymorphisms, factor V, prothrombin, 5,10-methylenetetrahydrofolate reductase, plasminogen activator inhibitor-1, and human platelet alloantigens) in patients with cryptogenic ischemic stroke and in patients with ischemic stroke of determined cause.

KW - Cryptogenic stroke

KW - Juvenile ischemic stroke

KW - Prothrombotic genetic polymorphisms

UR - http://www.scopus.com/inward/record.url?scp=72849153424&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=72849153424&partnerID=8YFLogxK

U2 - 10.4103/0028-3886.57819

DO - 10.4103/0028-3886.57819

M3 - Article

C2 - 19934566

AN - SCOPUS:72849153424

VL - 57

SP - 636

EP - 637

JO - Neurology India

JF - Neurology India

SN - 0028-3886

IS - 5

ER -